Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
health
10
×
crispr
science
tc
biology
medicine
non-coding rna
repetitive dna sequences
bio
biotechnology
editas medicine
extreme
medical
1861 establishments in massachusetts
1963 births
1987 establishments in texas
23andme
american biochemists
american women scientists
annual events in texas
archive
association of american universities
berkeley
berkeley college of chemistry faculty
bill gates
biological engineering
column
computer conferences
coronavirus
covid-19
crispr cas9
crispr therapeutics
crystallographers
cultural festivals in the united states
drama
educational institutions established in 1861
electronic music festivals in the united states
emerging technologies
emmanuelle charpentier
engineering disciplines
What
crispr
10
×
editing
gene
technology
read
using
based
biotech
cas
future
genes
genetic
high
new
patent
promises
public
successful
test
today
trial
use
used
year
ability
access
advances
afternoon
alexandria
allegedly
alter
ambitious
andme
animal
animals
applications
approval
approves
award
babies
Language
unset
Current search:
health
×
crispr
×
@bgr.com
2 years ago
First CRISPR cure for high cholesterol enters human trial phase
@extremetech.com
4 years ago
FDA Approves CRISPR-Based Coronavirus Test
@engadget.com
5 years ago
CRISPR gene editing has been used on humans in the US
@slashgear.com
5 years ago
China’s gene-edited CRISPR babies may have enhanced memory
@extremetech.com
6 years ago
Scientists Use CRISPR to Block HIV Replication Inside Living Cells
@techcrunch.com
7 years ago
CRISPR pioneer Jennifer Doudna shines hope on the future of genetic modification at SXSW
@techcrunch.com
7 years ago
Judge rules CRISPR-Cas9 patents belong to Broad Institute of Harvard and MIT
@techcrunch.com
7 years ago
CRISPR loses Nobel to tiny machines
@techcrunch.com
8 years ago
Innovation in genomics and the future of medtech
@techcrunch.com
8 years ago
Editas biotech stock drops by 26% over CRISPR patent dispute